Working… Menu

Study of Safety, Tolerability and Efficacy of PBKR03 in Pediatric Subjects With Early Infantile Krabbe Disease (GALax-C)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04771416
Recruitment Status : Not yet recruiting
First Posted : February 25, 2021
Last Update Posted : February 25, 2021
Information provided by (Responsible Party):
Passage Bio, Inc.

No Study Results Posted on for this Study
Recruitment Status : Not yet recruiting
Estimated Primary Completion Date : January 2027
Estimated Study Completion Date : January 2030